Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects

NCT07169240 is registered in ClinicalTrials.gov with ScinnoHub Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07169240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07169240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects
Lead sponsor
ScinnoHub Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
February 6, 2023
Completion date
August 2, 2025
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects (hs)